Dr. Qassim Ali Abid, MD

Dr. Abid practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Abid's NPI, 1194071712, was assigned on August 1, 2012. Dr. Abid graduated from University of Al-Mustansiriyah College of Medicine in 1999. Dr. Abid's Oklahoma license number on file is 34989.

Dr. Abid's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Abid's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Abid is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Abid to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abid practices, 4 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Abid's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Abid is board certified in pediatric nephrology by the American Board of Pediatrics. Dmand AI has Dr. Abid's licenses on file in 4 states: Oklahoma, Michigan, New Jersey and Pennsylvania.

CMS data shows 55 Medicare services from Dr. Abid across 1 procedure code in 2024, all of them office visits, for 16 Medicare patients. Medicare paid $5,413 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 16 Medicare patients who saw Dr. Abid in 2024. The largest group is under 65, with 16 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 4.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abid's median patient age at 12, with 38% women.

In 2024, Dr. Abid wrote 168 Medicare Part D claims for 13 patients. 94% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $693 in total drug cost. In 2023, CMS named 116 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Abid for performance year 2024, reported as part of a group. Dr. Abid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Abid, published from 2019 to 2020. Dr. Abid's most frequent co-authors are Rudolph P. Valentini, MD, Basim Isa Asmar, MD and Melissa Jane Gregory, MD.

CMS Open Payments shows 5 general payments to Dr. Abid from 2 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 67% of the total. Azurity Pharmaceuticals, Inc. paid the most, $23.

Dr. Abid graduated from University of Al-Mustansiriyah College of Medicine in 1999.

Dr. Abid is in network with 6 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.